ProfileGDS5822 / ILMN_2737460
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 25% 41% 44% 1% 7% 21% 1% 14% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 114.225
GSM1276600PDAC Late Ablation Control 220.641
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 117.244
GSM1276603PDAC Late Ablation 22.61
GSM1276604PDAC Late Ablation 36.77
GSM1303940PDAC Late Ablation_anti-CTLA4 113.121
GSM1303941PDAC Late Ablation_anti-CTLA4 21.31
GSM1303942PDAC Late Ablation_anti-CTLA4 38.114